These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8280719)

  • 1. Heat shock protein vaccines against cancer.
    Blachere NE; Udono H; Janetzki S; Li Z; Heike M; Srivastava PK
    J Immunother Emphasis Tumor Immunol; 1993 Nov; 14(4):352-6. PubMed ID: 8280719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of MHC class I-restricted tumor antigen peptide and its precursors associated with heat shock proteins hsp70, hsp90, and gp96.
    Ishii T; Udono H; Yamano T; Ohta H; Uenaka A; Ono T; Hizuta A; Tanaka N; Srivastava PK; Nakayama E
    J Immunol; 1999 Feb; 162(3):1303-9. PubMed ID: 9973383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human heat shock protein-specific cytotoxic T lymphocytes display potent antitumour immunity in multiple myeloma.
    Li R; Qian J; Zhang W; Fu W; Du J; Jiang H; Zhang H; Zhang C; Xi H; Yi Q; Hou J
    Br J Haematol; 2014 Sep; 166(5):690-701. PubMed ID: 24824351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity of mixed heat shock protein/peptide vaccine and cyclophosphamide plus interleukin-12 in mice sarcoma.
    Guo QY; Yuan M; Peng J; Cui XM; Song G; Sui X; Lu SB
    J Exp Clin Cancer Res; 2011 Feb; 30(1):24. PubMed ID: 21352555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of heat shock protein-peptide complexes on tumor and infectious diseases immunity].
    Meng SD; Gao F; Tien P
    Sheng Wu Gong Cheng Xue Bao; 2000 Jul; 16(4):425-8. PubMed ID: 11051811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy using heat-shock protein preparations of leukemia cells after syngeneic bone marrow transplantation in mice.
    Sato K; Torimoto Y; Tamura Y; Shindo M; Shinzaki H; Hirai K; Kohgo Y
    Blood; 2001 Sep; 98(6):1852-7. PubMed ID: 11535521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96.
    Arnold D; Faath S; Rammensee H; Schild H
    J Exp Med; 1995 Sep; 182(3):885-9. PubMed ID: 7650492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90, and hsp70.
    Udono H; Srivastava PK
    J Immunol; 1994 Jun; 152(11):5398-403. PubMed ID: 8189059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting heat shock proteins for immunotherapy in multiple myeloma: generation of myeloma-specific CTLs using dendritic cells pulsed with tumor-derived gp96.
    Qian J; Wang S; Yang J; Xie J; Lin P; Freeman ME; Yi Q
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8808-15. PubMed ID: 16361569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-derived heat shock protein 70-pulsed dendritic cells elicit tumor-specific cytotoxic T lymphocytes (CTLs) and tumor immunity.
    Ueda G; Tamura Y; Hirai I; Kamiguchi K; Ichimiya S; Torigoe T; Hiratsuka H; Sunakawa H; Sato N
    Cancer Sci; 2004 Mar; 95(3):248-53. PubMed ID: 15016325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heat shock proteins transfer peptides during antigen processing and CTL priming.
    Srivastava PK; Udono H; Blachere NE; Li Z
    Immunogenetics; 1994; 39(2):93-8. PubMed ID: 8276462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro reconstitution of heat shock protein-peptide complexes for generating peptide-specific vaccines against cancers and infectious diseases.
    Li Z
    Methods; 2004 Jan; 32(1):25-8. PubMed ID: 14624873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification of multiple heat shock proteins from a single tumor sample.
    Ménoret A; Bell G
    J Immunol Methods; 2000 Apr; 237(1-2):119-30. PubMed ID: 10725457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo and in vitro activation of T cells after administration of Ag-negative heat shock proteins.
    Breloer M; Fleischer B; von Bonin A
    J Immunol; 1999 Mar; 162(6):3141-7. PubMed ID: 10092763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of heat shock protein-based vaccines by intracellular loading of gp96 with antigenic peptides.
    Heikema A; Agsteribbe E; Wilschut J; Huckriede A
    Immunol Lett; 1997 Jun; 57(1-3):69-74. PubMed ID: 9232428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific immunogenicity of heat shock protein gp96 derives from chaperoned antigenic peptides and not from contaminating proteins.
    Binder RJ; Kelly JB; Vatner RE; Srivastava PK
    J Immunol; 2007 Dec; 179(11):7254-61. PubMed ID: 18025167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A broadly applicable, personalized heat shock protein-mediated oncolytic tumor vaccine.
    Huang XF; Ren W; Rollins L; Pittman P; Shah M; Shen L; Gu Q; Strube R; Hu F; Chen SY
    Cancer Res; 2003 Nov; 63(21):7321-9. PubMed ID: 14612530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of PSA-specific CD8+ CTL responses and antitumor immunity generated by plasmid DNA vaccines encoding PSA-HSP chimeric proteins.
    Pavlenko M; Roos AK; Leder C; Hansson LO; Kiessling R; Levitskaya E; Pisa P
    Cancer Immunol Immunother; 2004 Dec; 53(12):1085-92. PubMed ID: 15696608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heat shock protein-based cancer vaccines and related thoughts on immunogenicity of human tumors.
    Blachere NE; Srivastava PK
    Semin Cancer Biol; 1995 Dec; 6(6):349-55. PubMed ID: 8938273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heat shock fusion proteins as vehicles for antigen delivery into the major histocompatibility complex class I presentation pathway.
    Suzue K; Zhou X; Eisen HN; Young RA
    Proc Natl Acad Sci U S A; 1997 Nov; 94(24):13146-51. PubMed ID: 9371814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.